NCT04654611View on ClinicalTrials.gov

Tafluprost Preservative Free Switch Study

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

February 1, 2020

Study Completion Date

February 1, 2020

Conditions
GlaucomaPrimary Open Angle GlaucomaOcular Hypertension
Interventions
DRUG

preservative free tafluprost 0.0015%

preservative free prostaglandin analogue option for treatment of primary open angle glaucoma and ocular hypertension patients

Trial Locations (1)

46200

THONEH, Petaling Jaya

All Listed Sponsors
lead

Tun Hussein Onn National Eye Hospital

OTHER

NCT04654611 - Tafluprost Preservative Free Switch Study | Biotech Hunter | Biotech Hunter